Global Cardiac Resynchronization Therapy Market Outlook

The global cardiac resynchronization therapy (CRT) market size was valued at USD 4.74 billion in 2016 and is expected to grow at a CAGR of 7.9% over the forecast period. Increasing incidence of heart failure(s) & other cardiac disorders, stable R&D investment for technological advancements by players, and rising sedentary lifestyle amongst the population are expected to promote growth over the forecast period.
Cardiac resynchronization treatment was launched at the end of the twentieth century. It has brought a paradigm shift in medical treatment and has proved a boon for patients with systolic heart failure symptoms. The key objective of cardiac resynchronization therapy is restoring mechanical synchrony through electric activation of the heart in a synchronized way.

Top Driver: Robust technological advancements in CRT devices will further augment market growth
Moreover, increasing technological advancements in CRT devices will further augment market growth. For instance, companies such as Medtronic and Abbott are focusing on technological advancements related to cardiac devices. Additionally, increasing government initiatives for the treatment of various cardiovascular diseases will further propel industry growth.
The cardiac resynchronization therapy defibrillators segment is expected to witness substantial growth across the forecast timeframe. High growth is attributed to the increasing prevalence of cardiovascular diseases across the globe. Moreover, the increasing rate of the geriatric population prone to cardiac and other chronic diseases will further propel market growth.
The hospitals segment will show significant growth over the analysis timeframe, owing to the rising adoption of CRT devices in hospital settings. Moreover, the presence of well-equipped and innovative devices in these amenities will further boost industry growth across the projected timeframe. Also, the increasing preference among the population for hospitals over other medical settings due to the presence of required facilities is another major growth propelling factor.

CRT-D to Make Crucial Contribution to Growth of Global Cardiac Resynchronization Therapy Market
CRT-Ds segment accounted for the largest share of the CRT market. On the basis of product type, the global market is segmented into cardiac resynchronization therapy Defibrillators(CRT-Ds) and cardiac resynchronization therapy Pacemakers (CRT-Ps). The CRT-Ds segment accounted for the largest share of the market in 2018. This is majorly attributed to the increasing acceptance of CRT-Ds over pacemakers and the launch of technologically advanced devices. Furthermore, growth in this market segment is largely driven by the increasing incidence of target diseases.

In 2018, hospitals & cardiac centers accounted for the largest share of the cardiac resynchronization therapy market. On the basis of end-user, the market is segmented into hospitals & cardiac centers, and ambulatory surgery centers. Hospitals & cardiac centers accounted for the largest share of the market in 2018. The increasing prevalence of CVD, rising number of surgical procedures performed, favorable reimbursement scenario, and the increasing number of critical care and intensive care units are some of the key factors driving the growth of the hospitals & cardiac centers segment.
Rising approvals by U.S. FDA for new products and increasing the growth of the geriatric population suffering from cardiac dysfunction to Benefit North America Market
The North American region is expected to contribute the highest revenue over the forecast period due to rising approvals by the U.S. FDA for new products and increasing the growth of the geriatric population suffering from cardiac dysfunction. As of 2016, it held more than 36.0% of the global market share.

Europe also held a substantial share and is predicted to witness lucrative growth with a CAGR of more than 7.4% over the next nine years. Higher stringency being implemented by the healthcare agencies toward R&D, safety guideline follow-up, and product approvals are expected to drive the growth.
Players to Focus on Expanding Applications in Global Cardiac Resynchronization Therapy Market
Prominent players in the cardiac resynchronization therapy market are Medtronic (Ireland), Abbott (US), Boston Scientific Corporation (US), MicroPort Scientific Corporation (China), BIOTRONIK (Germany), and Medico S.p.A. (Italy).

Medtronic: is a medical technology company that manufactures, designs, develops and markets a wide range of solutions and medical devices used in the treatment of cardiac, spinal, neurological, vascular, and chronic conditions. The company is one of the major players in the CRT systems market. With a strong brand name and wide geographic coverage in more than 160 countries, Medtronic has a well-established presence in this market. As a part of its global growth strategy, the company pursues organic growth strategies, such as product approvals. The company is also investing a large sum into its expansion projects to increase its global presence. In this regard, the company opened its Asia Pacific headquarters in Singapore to support operations at 80 locations in this region.

Scope of the Report
By Product Type
Cardiac Resynchronization Therapy Defibrillators
Cardiac Resynchronization Therapy Pacemakers
By End-User
Hospitals & Cardiac Centers
Ambulatory Surgery Centers
By Region
North America
Europe
Asia Pacific
Rest Of World

Key Reasons to Purchase this Report

1. It provides a technological development map over time to understand the growth rate of the industry.

2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.

3. It renders a definite analysis for changing competitive dynamics.

4. It builds a seven-year estimate based on how the market is predicted to grow.

Chapter 1 Overview And Scope
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
1.2 Market Segmentation

Chapter 2 Our Research Practice
2.1 Our Research Methodology
2.2 Data Triangulation
2.3 Data Sources
2.4 Assumptions for the study
2.5 Approach Adopted

Chapter 3 Executive Summary
3.1 Market Snapshot
3.2 Regional Snapshot
3.3 Segment Summary
Chapter 4 Covid-19 Impact Analysis
4.1 Overview
4.2 Prevalence analysis
4.3 Key Factor Impact Analysis

Chapter 5 Global Cardiac Resynchronization therapy Market Forces
5.1 Whats Driving the Market
5.2 Porters Five Forces Analysis
5.2.1 Power of Suppliers
5.2.2 Threats From New Entrants
5.2.3 Power of Buyer
5.2.4 Threat From Substitute Product
5.2.5 Degree of Competition

Chapter 6 Global Cardiac Resynchronization therapy Market -Industry Snapshots
6.1 Overview
6.1.1 Global Cardiac Resynchronization therapy Market Value, 2019 - 2028, (US$ Bn)
6.2 Market Overview
6.2.1 Drivers Analysis
6.2.2 Restraint/Challenges analysis
6.2.3 Opportunity Analysis
6.3 Supply Chain/Value Chain Analysis
6.4 Market SWOT Analysis

Chapter 7 Global Cardiac Resynchronization therapy Market Analysis, by Product
7.1 Overview
7.2 Key Findings for Cardiac Resynchronization therapy Market- By Product
7.2.1 Cardiac Resynchronization therapy Market- Thermosets Cardiac Resynchronization Therapy Defibrillators
7.2.2 Cardiac Resynchronization therapy Market- Cardiac Resynchronization Therapy Pacemakers
Cardiac Resynchronization therapy market by Product 2, 2019 - 2028 (USD Million)

Chapter 8 Global Cardiac Resynchronization therapy Market Analysis, by Product Type
8.1 Overview
8.2 Key Findings for Cardiac Resynchronization therapy Market- By Product Type
8.2.1 Cardiac Resynchronization therapy Market- polyurethane
8.2.2 Cardiac Resynchronization therapy Market- polyethylene terephthalate (pet)
8.2.3 Cardiac Resynchronization therapy Market- Polyethylene
8.2.4 Cardiac Resynchronization therapy Market- polypropylene

Chapter 9 Cardiac Resynchronization therapy Market Analysis by Region
9.1 Key Findings for Cardiac Resynchronization therapy Market- By region
9.2 Overview
9.2.1 Global Cardiac Resynchronization therapy Market Analysis, By Type, 2019 - 2028
9.2.2 Global Cardiac Resynchronization therapy Market Analysis, By Product Type, 2019 - 2028
9.3 Cardiac Resynchronization therapy Market North America
9.3.1 Overview
9.3.2 U.S.
9.3.3 Canada
9.3.4 Mexico
9.3.5 North America Market, By Type
9.3.6 North America Market, By Product Type
9.4 Cardiac Resynchronization therapy Market Europe
9.4.1 Overview
9.4.2 Germany
9.4.3 United Kingdom
9.4.4 France
9.4.5 Italy
9.4.6 Rest Of Europe
9.4.7 Europe Market, By Type
9.4.8 Europe Market, By Product Type
9.5 Cardiac Resynchronization therapy Market Asia Pacific
9.5.1 Overview
9.5.2 China
9.5.3 Japan
9.5.4 India
9.5.5 Rest of APAC
9.5.6 Asia Pacific Market, By Type
9.5.7 Asia Pacific Market, By Product Type
9.6 Cardiac Resynchronization therapy Market Rest Of World
9.6.1 Overview
9.6.2 Middle East & Africa (MEA)
9.6.3 South America
9.6.4 Rest Of World
9.6.5 South America, Middle East and Africa Market, By Type
9.6.6 South America, Middle East and Africa Market, By Product Type

Chapter 10 Market Competition Analysis
10.1 Market Share/Positioning Analysis
10.1.1 Market Positioning of Key Vendors, 2019
10.1.2 Key Strategies Adopted by the Leading Players
10.1.3 Recent Developments

Chapter 11 Company Profiles- Snapshot
11.1 Medico S.p.A. (Italy).
11.1.1 Business Fundamentals
11.1.2 Financial Snapshots
11.1.3 Product Portfolio
11.1.4 Recent Developments
11.2 Medtronic (Ireland),
11.3 Abbott (US),
11.4 Boston Scientific Corporation (US),
11.5 MicroPort Scientific Corporation (China),
11.6 BIOTRONIK (Germany),
*More than 10 Companies are profiled in this Research Report*
*Financials would be provided on a best efforts basis for private companies

Chapter 12 Appendix


.

List Of Tables

TABLE 1 Cardiac Resynchronization therapy market by Product 1, 2019 - 2028 (USD Million)
TABLE 2 Cardiac Resynchronization therapy market by Product Type 1, 2019 - 2028 (USD Million)
TABLE 3 Cardiac Resynchronization therapy market by Product Type 2, 2019 - 2028 (USD Million)
TABLE 4 Cardiac Resynchronization therapy market by Product Type 3, 2019 - 2028 (USD Million)
TABLE 5 Cardiac Resynchronization therapy market by Product Type 4, 2019 - 2028 (USD Million)
TABLE 6 Global Cardiac Resynchronization therapy Market Value, By Type, 2019 - 2028 (US$ Bn)
TABLE 7 Global Cardiac Resynchronization therapy Market Value, By Product Type, 2019 - 2028 (US$ Bn)
TABLE 8 Cardiac Resynchronization therapy Market Analysis by North America (USD Million), 2019 - 2028
TABLE 9 U.S. Cardiac Resynchronization therapy Market, 2019 - 2028 (USD Million)
TABLE 10 U.S. Cardiac Resynchronization therapy Market, By Type, 2019 - 2028 (USD Million)
TABLE 11 U.S. Cardiac Resynchronization therapy Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 12 Canada Cardiac Resynchronization therapy Market, 2019 - 2028 (USD Million)
TABLE 13 Canada Cardiac Resynchronization therapy Market, By Type, 2019 - 2028 (USD Million)
TABLE 14 Canada Cardiac Resynchronization therapy Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 15 Mexico Cardiac Resynchronization therapy Market, 2019 - 2028 (USD Million)
TABLE 16 Mexico Cardiac Resynchronization therapy Market, By Type, 2019 - 2028 (USD Million)
TABLE 17 Mexico Cardiac Resynchronization therapy Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 18 Cardiac Resynchronization therapy Market Analysis by Europe (USD Million), 2019 - 2028
TABLE 19 Germany Cardiac Resynchronization therapy Market, 2019 - 2028 (USD Million)
TABLE 20 Germany Cardiac Resynchronization therapy Market, By Type, 2019 - 2028 (USD Million)
TABLE 21 Germany Cardiac Resynchronization therapy Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 22 United Kingdom Cardiac Resynchronization therapy Market, 2019 - 2028 (USD Million)
TABLE 23 United Kingdom Cardiac Resynchronization therapy Market, By Type, 2019 - 2028 (USD Million)
TABLE 24 United Kingdom Cardiac Resynchronization therapy Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 25 France Cardiac Resynchronization therapy Market, 2019 - 2028 (USD Million)
TABLE 26 France Cardiac Resynchronization therapy Market, By Type, 2019 - 2028 (USD Million)
TABLE 27 France Cardiac Resynchronization therapy Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 28 Italy Cardiac Resynchronization therapy Market, 2019 - 2028 (USD Million)
TABLE 29 Italy Cardiac Resynchronization therapy Market, By Type, 2019 - 2028 (USD Million)
TABLE 30 Italy Cardiac Resynchronization therapy Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 31 Rest Of Europe Cardiac Resynchronization therapy Market, 2019 - 2028 (USD Million)
TABLE 32 Rest Of Europe Cardiac Resynchronization therapy Market, By Type, 2019 - 2028 (USD Million)
TABLE 33 Rest Of Europe Cardiac Resynchronization therapy Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 34 Cardiac Resynchronization therapy Market Analysis by Asia Pacific (USD Million), 2019 - 2028
TABLE 35 China Cardiac Resynchronization therapy Market, 2019 - 2028 (USD Million)
TABLE 36 China Cardiac Resynchronization therapy Market, By Type, 2019 - 2028 (USD Million)
TABLE 37 China Cardiac Resynchronization therapy Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 38 Japan Cardiac Resynchronization therapy Market, 2019 - 2028 (USD Million)
TABLE 39 Japan Cardiac Resynchronization therapy Market, By Type, 2019 - 2028 (USD Million)
TABLE 40 Japan Cardiac Resynchronization therapy Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 41 India Cardiac Resynchronization therapy Market, 2019 - 2028 (USD Million)
TABLE 42 India Cardiac Resynchronization therapy Market, By Type, 2019 - 2028 (USD Million)
TABLE 43 India Cardiac Resynchronization therapy Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 44 Rest of APAC Cardiac Resynchronization therapy Market, 2019 - 2028 (USD Million)
TABLE 45 Rest of APAC Cardiac Resynchronization therapy Market, By Type, 2019 - 2028 (USD Million)
TABLE 46 Rest of APAC Cardiac Resynchronization therapy Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 47 Cardiac Resynchronization therapy Market Analysis by Rest Of World (USD Million), 2019 - 2028
TABLE 48 Middle East & Africa (MEA) Cardiac Resynchronization therapy Market, 2019 - 2028 (USD Million)
TABLE 49 Middle East & Africa (MEA) Cardiac Resynchronization therapy Market, By Type, 2019 - 2028 (USD Million)
TABLE 50 Middle East & Africa (MEA) Cardiac Resynchronization therapy Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 51 South America Cardiac Resynchronization therapy Market, 2019 - 2028 (USD Million)
TABLE 52 South America Cardiac Resynchronization therapy Market, By Type, 2019 - 2028 (USD Million)
TABLE 53 South America Cardiac Resynchronization therapy Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 54 Rest Of World Cardiac Resynchronization therapy Market, 2019 - 2028 (USD Million)
TABLE 55 Rest Of World Cardiac Resynchronization therapy Market, By Type, 2019 - 2028 (USD Million)
TABLE 56 Rest Of World Cardiac Resynchronization therapy Market, By Product Type, 2019 - 2028 (USD Million)
Chapter 1

List Of Figures

FIG. 1 Global Cardiac Resynchronization therapy : Market Segmentation
FIG. 2 Global Cardiac Resynchronization therapy Market: Research Methodology
FIG. 3 Top-Down and Bottom Up Approach
FIG. 4 Market Snapshot
FIG. 5 Porters Five Forces Analysis
FIG. 6 Global Cardiac Resynchronization therapy Market Value, 2019 - 2028, (US$ Bn)
FIG. 7 Supply Chain/Value Chain Analysis
FIG. 8 Global Cardiac Resynchronization therapy Market Value Contribution, By Type, 2019 & 2026 (%)
FIG. 9 Global Cardiac Resynchronization therapy Market Value Contribution, By Product Type, 2019 & 2026 (%)
FIG. 10 Global Cardiac Resynchronization therapy Market Value, 2019 - 2028, (US$ Bn)
FIG. 11 North America Cardiac Resynchronization therapy Market Value, 2019 - 2028, (US$ Bn)
FIG. 12 Cardiac Resynchronization therapy Market Segment 1 North America
FIG. 13 Cardiac Resynchronization therapy Market Segment 2 North America
FIG. 14 Cardiac Resynchronization therapy U.S. outlook, 2019 & 2026
FIG. 15 Cardiac Resynchronization therapy Canada outlook, 2019 & 2026
FIG. 16 Cardiac Resynchronization therapy Mexico outlook, 2019 & 2026
FIG. 17 Europe Cardiac Resynchronization therapy Market Value, 2019 - 2028, (US$ Bn)
FIG. 18 Cardiac Resynchronization therapy Market Segment 1 Europe
FIG. 19 Cardiac Resynchronization therapy Market Segment 2 Europe
FIG. 20 Cardiac Resynchronization therapy Germany outlook, 2019 & 2026
FIG. 21 Cardiac Resynchronization therapy United Kingdom outlook, 2019 & 2026
FIG. 22 Cardiac Resynchronization therapy France outlook, 2019 & 2026
FIG. 23 Cardiac Resynchronization therapy Italy outlook, 2019 & 2026
FIG. 24 Cardiac Resynchronization therapy Rest Of Europe outlook, 2019 & 2026
FIG. 25 Asia Pacific Cardiac Resynchronization therapy Market Value, 2019 - 2028, (US$ Bn)
FIG. 26 Cardiac Resynchronization therapy Market Segment 1 Asia Pacific
FIG. 27 Cardiac Resynchronization therapy Market Segment 2 Asia Pacific
FIG. 28 Cardiac Resynchronization therapy China outlook, 2019 & 2026
FIG. 29 Cardiac Resynchronization therapy Japan outlook, 2019 & 2026
FIG. 30 Cardiac Resynchronization therapy India outlook, 2019 & 2026
FIG. 31 Cardiac Resynchronization therapy Rest of APAC outlook, 2019 & 2026
FIG. 32 Rest Of World Cardiac Resynchronization therapy Market Value, 2019 - 2028, (US$ Bn)
FIG. 33 Cardiac Resynchronization therapy Market Segment 1 Rest Of World
FIG. 34 Cardiac Resynchronization therapy Market Segment 2 Rest Of World
FIG. 35 Cardiac Resynchronization therapy Middle East & Africa (MEA) outlook, 2019 & 2026
FIG. 36 Cardiac Resynchronization therapy South America outlook, 2019 & 2026
FIG. 37 Cardiac Resynchronization therapy Rest Of World outlook, 2019 & 2026